A detailed picture of what happens when DNA transcription is paused early in the process has been obtained by structural ...

Het Hooggerechtshof had eerder geoordeeld dat een van Moderna’s patenten met betrekking tot messenger RNA (mRNA)-technologie ...

Known as promoter-proximal pausing, this interruption in the transcription activity of RNA polymerase II—the enzyme ...

Trump administration has unwisely cancelled mRNA vaccine research while doing little about Americans’ unhealthy diet.

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

NIH director Jay Bhattacharya has offered a new explanation for why the federal government canceled $500 million in contracts ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Market to Reach $430 Million by 2032, Driven by Breakthrough Clinical Trials and Expanding Indications. The global RNA-Based Therape ...